Reiman, Eric M.
Article History
First Online: 13 January 2017
Competing interests
: E.M.R. is a scientific adviser to Alkahest, Alzheon, Biogen, CereSpir, Denali and Pfizer. He and his parent organization have received research grants from Genentech/Roche, Novartis/Amgen, and Avid/Lilly. He is the inventor of a patent, entitled “Accelerated evaluation of treatments to prevent clinical onset of Alzheimer's disease.”